Content Currently Unavailable
Rewriting the Neuroscience Playbook
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
Content Currently Unavailable
False
Advertisement
Related Content
Development & Clinical
Small Molecules
Interviews
Musings from The Power List: Christine Allen
August 28, 2026
2 min read
Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise
Biopharma
Industry News
Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines
August 26, 2026
7 min read
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field
Cell & Gene
Development & Clinical
Business & Trends
The Biggest Bottlenecks Holding Back Cell and Gene Therapy
August 24, 2026
9 min read
Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges
Small Molecules
Drug Discovery
Development & Clinical
Musings from The Power List: Daniel Vitt
August 20, 2026
6 min read
From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development